Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Luka Rotkvić"'
Autor:
Vito Mustapić, Mladen Predrijevac, Dario Dilber, Luka Rotkvić, Andrija Škopljanac Mačina, Igor Šesto, Krešimir Štambuk
Publikováno v:
Acta Clinica Croatica, Vol 63., Iss Supplement 1, Pp 96-99 (2024)
Coronary subclavian steal syndrome (CSSS) is an uncommon complication of coronary artery bypass graft (CABG) surgery when the left internal mammary artery (LIMA) is used in patients with underdiagnosed significant left subclavian artery stenosis (S
Externí odkaz:
https://doaj.org/article/76f88003795040ab808b4d07d4b46c20
Autor:
Luka Rotkvić, Iva Mišljenčević, Alan Jelić, Andrija Škopljanac Mačina, Igor Šesto, Krešimir Štambuk
Publikováno v:
Acta Clinica Croatica, Vol 63., Iss Supplement 1, Pp 105-109 (2024)
Introduction. Transcatheter aortic valve implantation (TAVI) is a treatment method for aortic stenosis with proven efficacy and recommended by professional societies in the cardiovascular field. Complications during TAVI are rare but important and
Externí odkaz:
https://doaj.org/article/433ff1a22fbb4a80a1652b7d6631ddde
Autor:
Alan Jelić, Mladen Predrijevac, Luka Rotkvić, Valentina Slivnjak, Igor Šesto, Janko Szavits Nossan, Andrija Škopljanac Mačina, Krešimir Štambuk
Publikováno v:
Acta Clinica Croatica, Vol 63., Iss Supplement 1, Pp 111-114 (2024)
TAVI (Transcatheter Aortic Valve Implantation) is a minimally invasive procedure for the treatment of severe aortic stenosis (AS) in elderly and comorbid patients. Following the guidelines of eminent cardiac societies, a decision on the treatment m
Externí odkaz:
https://doaj.org/article/e621dfe754c94a3a9dd91c4ecde9a7a7
Publikováno v:
World Journal of Diabetes
Three major cardiovascular outcome trials (CVOTs) with a new class of antidiabetic drugs - sodium- glucose cotransporter 2 (SGLT2) inhibitors (EMPA-REG OUTCOME trial with empagliflozin, CANVAS Program with canagliflozin, DECLARE-TIMI 58 with dapaglif
Publikováno v:
Cardiologia Croatica
Volume 17
Issue 9-10
Volume 17
Issue 9-10
Autor:
Tomislav Sipic, Igor Sesto, Luka Rotkvić, Robert Bernat, Janko Szavits Nossan, Marinko Žulj, Ivan Gudelj, Krešimir Štambuk, Jure Mirat
Publikováno v:
Kardiologia Polska.
Background: Left atrial (LA) fibrosis is associated with a higher rate of recurrence of atrial fibrillation (AF) after pulmonary vein isolation (PVI). Body mass index (BMI) is strongly associated with the prevalence of AF, but there is insufficient d
One of the main risk factors influencing patient survival after heart transplantation is cardiac allograft vasculopathy, the leading cause of death after the first year of transplantation. It is an entity of multifactorial origin including both humor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df2311ac2800d32334c1e49f62a12f30
https://doi.org/10.1016/j.mehy.2020.109594
https://doi.org/10.1016/j.mehy.2020.109594
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a class of drugs that promote urinary glucose excretion in the treatment of diabetes, have provoked large interest of scientific and professional community due to their positive and, somehow, unexpec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd3ece581f25856583a8d2d06d223b6
https://www.bib.irb.hr/1017471
https://www.bib.irb.hr/1017471
Autor:
SANJA SAKAN, DAVORKA PRAJDIĆ-PREDRIJEVAC, VLADO JURANKO, MLADEN NOVKOSKI, ZDENKO POVŠIĆ-ČEVRA, JANKO SZAVITS-NOSSAN, IGOR ŠESTO, MARIJA RAZUM, LUKA ROTKVIĆ, IVAN BUDIMIR, NIVES TODORIĆ, NATAŠA ANDRIJAŠEVIĆ, ZVONIMIR ANTE KORDA
Publikováno v:
Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske
Volume 72
Issue 3
Volume 72
Issue 3
Prema dosadašnjim istraživanjima neracionalna primjena antimikrobne terapije značajan je problem u bolničkim i vanbolničkim ustanovama. Studije su pokazale da se približno 50 % antimikrobnih lijekova koristi nepotrebno i suboptimalno s obzirom
Autor:
Vedran Bursic, Vesna Pehar-Pejčinović, Iva Uravić Bursać, Dijana Travica Samsa, Rajko Miskulin, Marijana Rakić, Damir Raljević, Viktor Peršić, Luka Rotkvić
Publikováno v:
Cardiologia Croatica. 13:414-414